M30.3
Mucocutaneous lymph node syndrome [Kawasaki]
Clinical Classification Guidelines
Medical Intelligence & Overview
Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a rare but serious condition that primarily affects children. It involves inflammation of blood vessels throughout the body, which can lead to complications if not diagnosed and treated promptly. Recognized by its characteristic symptoms and signs, Kawasaki disease requires medical attention to reduce the risk of heart-related problems later on.
Causes & Symptoms
Clinical Causes: The exact cause remains unknown, but it is believed to involve an abnormal immune response possibly triggered by infections. Genetic factors may play a role, as the condition can sometimes run in families. Environmental factors and certain bacterial or viral infections are being studied as potential triggers.
Key Symptoms: High fever lasting more than five days Red, swollen eyes without discharge Strawberry-like appearance of the tongue and redness inside the mouth Swollen or red hands and feet, sometimes with peeling skin Skin rashes often appear on the torso and genital area Swollen lymph nodes in the neck Irritability or fussiness, especially in young children
Diagnostic & Treatment
Diagnosis Path: Diagnosing Kawasaki disease involves a thorough clinical evaluation by a healthcare professional. Since there is no specific test for the disease, doctors rely on identifying a combination of symptoms and signs. Blood tests, such as inflammatory markers and a complete blood count, can support the diagnosis and help rule out other conditions. Echocardiography may be used to check for heart inflammation or aneurysms, which are potential complications.
Treatment Protocols: Intravenous immunoglobulin (IVIG) therapy to reduce inflammation and immune system activity High-dose aspirin during the acute phase to help decrease inflammation and prevent blood clots Follow-up care often involves low-dose aspirin for several weeks or months to monitor the heart health Additional treatments may be recommended based on the severity and response to initial therapy, including corticosteroids in resistant cases
Clinical Advice & FAQs
Billing Guidance
Is M30.3 a billable ICD-10 code?
Yes, M30.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M30.3?
Clinical documentation must specify the nature of Mucocutaneous lymph node syndrome [Kawasaki] and any associated comorbidities for accurate reporting.
Cite this Clinical Reference